Skip to main content

Military Health System

Genome Sequencing Assists Research at Naval Health Research Center

Image of Lab technicians doing genome research. Technicians at the Naval Health Research Center test blood samples for antibodies. The effort is part of the DOD SARS-CoV-2 Whole Genome Sequencing Action Plan, which brings together laboratories to conduct whole genome sequencing across the Military Health System in response to the COVID-19 pandemic. (Credit: NHRC John Marciano)

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

Editor’s note: This is the sixth installment in a 6-part series that highlights the work of the Military Health System laboratories and the technicians who worked to identify COVID-19 variants using special sequencing technology.

The staff at Naval Health Research Center (NHRC) added whole genome sequencing capability to their surveillance program. During the COVID-19 pandemic, NHRC brought on scientists and lab technicians to support this work and bioinformatics, which enriched their data collection and analysis capabilities.

“Coordination was a team effort. Lab technicians worked together to test samples, identify candidates for WGS, and ultimately perform the sequencing reactions. This data was handed off to NHRC scientists for process and analysis,” said U.S. Navy Lt. Cmdr. Michelle H. Lane, who holds a doctorate in biomedical science and is the director of operational infectious diseases at NHRC.

The U.S. Navy laboratory has access to a number of unique samples from naval vessels, U.S. and Mexico border populations, Department of Defense (DOD) beneficiaries, as well as recruits and trainees across all DOD services. These samples have been important to the DOD across multiple areas of responsibilities during the pandemic. NHRC continues to provide critical sequencing and epidemiological support for the COVID-19 efforts and have even developed a new serological quantitative assay that enables the differentiation between the immune response generated by natural infection compared to immunity generated through vaccination. Serology, in conjunction with molecular, sequencing, and bioinformatics data, will collectively inform a better understanding about vaccine efficacy metrics.

The Armed Forces Health Surveillance Division Global Emerging Infections Surveillance’s Next Generation Sequencing and Bioinformatics Consortium supported their efforts.

“In addition to the financial support, the consortium has shared knowledge and offered support in troubleshooting new protocols and procedures. These resources were critical in initiating the new WGS program,” said Lane.

She believes that this work is important to military and local civilian populations, adding, “Knowledge of diseases circulating in any population, military or civilian, is critical to keeping that population healthy. WGS offers a more precise, close-up look at these diseases and allows doctors and scientists to monitor disease evolution at a molecular level. All of this information contributes to more precise diagnoses and better treatment decisions.”

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Showing results 1 - 13 Page 1 of 1
Refine your search
Last Updated: January 24, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery